Monalizumab
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Monalizumab, covering 2023-03-09 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer [Phase 2]